James Edgemond
Chief Financial Officer and Treasurer
Replay available
United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call
United Therapeutics Corporation (NASDAQ: UTHR) Q2 2025 earnings conference call, held 2025-07-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
CQ Ding
Senior Vice President of Biostatistics, Statistical Programming and Data Management
Dr. Martine Rothlott
Chairperson and Chief Executive Officer
Dr. Lee Peterson
Executive Vice President of Product Development and Xenotransplantation
Michael Benkowitz
President and Chief Operating Officer
Dr. Gil Golden
Executive Vice President and Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.400 Good morning and welcome to the United Therapeutics Corporation second quarter 2025 00:00:05.400 -- 00:00:07.400 corporate update. 00:00:07.400 -- 00:00:11.300 My name is Steve and I will be your conference operator today. 00:00:11.300 -- 00:00:16.400 All participants on the call portion of this upcast will be in the listen only mode until 00:00:16.400 -- 00:00:20.580 the question and answer portion of this earnings call. 00:00:20.970 -- 00:00:26.200 If you would like to ask a question during this time simply press star then the number 00:00:26.200 -- 00:00:31.320 one on your telephone keypad. If you would like to withdraw a question simply 00:00:31.320 -- 00:00:35.080 press star then two on your telephone keypad. 00:00:35.080 -- 00:00:38.240 Please note this call is being recorded. 00:00:40.340 -- 00:00:44.740 I will now like to turn the upcast over to the US statement head of investor relations 00:00:44.740 -- 00:00:48.440 at United Therapeutics. Please go ahead. 00:00:48.440 -- 00:00:52.720 Thank you Steve and good morning. It's my pleasure to welcome you to the United Therapeutics 00:00:52.720 -- 00:00:57.360 Corporation second quarter 2025 corporate update webcast. 00:00:57.360 -- 00:01:01.060 Remarks today will include forward looking statements representing our expectations or 00:01:01.060 -- 00:01:05.120 beliefs regarding future events. These statements will involve risks and uncertainties 00:01:05.120 -- 00:01:08.320 that may cause actual results to differ materially. 00:01:08.320 -- 00:01:13.620 Our latest SEC filings including forms 10K and 10Q contain additional information on 00:01:13.620 -- 00:01:17.980 these risks and uncertainties. We assume no obligation to update these forward looking 00:01:17.980 -- 00:01:22.560 ...